TrademarkDir
KEYPHARMA
LIVE

Serial Number

88649091

Owner

Keysource Acquisition, LLC

Attorney

Carrie A. Johnson

First Use Date

Aug 9, 2023

Filing Date

Oct 10, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

KEYPHARMA Trademark

Serial Number: 88649091 • Registration: 7236721

KEYPHARMA is a trademark filed by Keysource Acquisition, LLC on October 10, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Keysource Acquisition, LLC (5 trademarks)

7820 Palace Drive
Cincinnati, OH 45249

Entity Type: 16

Trademark Details

Filing Date

October 10, 2019

Registration Date

December 5, 2023

First Use Anywhere

August 9, 2023

First Use in Commerce

August 9, 2023

Published for Opposition

July 21, 2020

Goods & Services

Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment and prevention of digestive, cardiovascular, immune system, urology, central nervous system, respiratory, bone, eye, ear, nose throat, dermatological, ophthalmological, endocrine, musculo-skeletal, obstetric and gynecological, urinary and gastrointestinal diseases, infections, and conditions; nutritional and dietary supplements

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 5, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 5, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 1, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 31, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 19, 2023 SUPC
USE AMENDMENT FILED
Aug 15, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 15, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 20, 2023 EXRA
SOU EXTENSION 5 GRANTED
Jan 19, 2023 EX5G
SOU EXTENSION 5 FILED
Jan 17, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 1, 2022 EXRA
SOU EXTENSION 4 GRANTED
Jun 29, 2022 EX4G
SOU EXTENSION 4 FILED
Jun 29, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 29, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2022 EXRA
SOU EXTENSION 3 GRANTED
Mar 1, 2022 EX3G
SOU EXTENSION 3 FILED
Mar 1, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 1, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 31, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 27, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 27, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 27, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2021 EXRA
SOU EXTENSION 1 GRANTED
Mar 3, 2021 EX1G
SOU EXTENSION 1 FILED
Mar 3, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 3, 2021 EEXT
CORRECTED NOA E-MAILED
Oct 28, 2020 NOAC
NOTICE OF ALLOWANCE CORRECTION ENTERED
Oct 27, 2020 ICNA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 27, 2020 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 16, 2020 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 15, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2020 TROA
ASSIGNED TO LIE
May 12, 2020 ALIE
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 7, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 7, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 7, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 7, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 7, 2020 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 17, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 17, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 17, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2019 NWOS
NEW APPLICATION ENTERED
Oct 14, 2019 NWAP

Related Trademarks

More from this Owner

KEYSOURCE PLUS

KEYSOURCE PLUS

KEYSOURCE PLUS

KEYSOURCE PLUS

KEYSOURCE +

KEYSOURCE +

KEYSOURCE +

KEYSOURCE +

KEY PHARMA

KEY PHARMA

KEY PHARMA

KEY PHARMA